ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, J. W.
Annals of Clinical & Laboratory Science 33:257-264 (2003)
© 2003 Association of Clinical Scientists

Association Between Elevated Serum Hepatic Enzyme Activity and Total Body Fat in Obese Humans

Jong Weon Choi
Department of Laboratory Medicine, College of Medicine, Inha University, Inchon, South Korea

Address correspondence to Jong Weon Choi, MD, PhD; Department of Laboratory Medicine, Inha University Hospital, 7-206, 3-ga, Shinheung-dong, Jung-gu, Inchon, 400-711, South Korea; tel 82 32 890 2503; fax 82 32 890 2529; e-mail jwchoi{at}inha.ac.kr.

To investigate the associations between obesity and serum hepatic enzyme activities, we measured total body fat (TBF), body mass index (BMI), and hepatic biochemical parameters in 732 apparently healthy adults. TBF was assessed using a body fat analyzer. Serum activities of alanine and aspartate aminotransferase (ALT and AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), and lactate dehydrogenase (LD) were determined by standard spectrophotometric methods. Mean activities (± SD) of serum ALT and AST in men with high fatness were 51.2 ± 12.6 U/L and 32.9 ± 9.2 U/L, which were significantly higher than those in men with low fatness (23.5 ± 7.4 U/L and 22.5 ± 7.8 U/L, p <0.01). Of 147 men with high fatness, 56 (38.1%) had serum ALT levels above the upper limit of normal, whereas only 9.5% (31/328) of men with low or desirable fatness showed elevated serum ALT activities (p <0.01). Serum ALT, AST, and GGT activities correlated significantly with TBF in both overweight men and women. Among subjects having high TBF, those with fatty liver showed significantly higher incidence of elevated hepatic enzymes, compared to those without fatty liver. In short, elevated serum hepatic enzyme activities are associated with TBF and a high prevalence of fatty liver is observed in subjects with elevated TBF.

Keywords: Obesity, total body fat, serum hepatic enzymes, fatty liver




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Rigazio, H.-R. Lehto, H. Tuunanen, K. Nagren, M. Kankaanpaa, C. Simi, R. Borra, A. G. Naum, R. Parkkola, J. Knuuti, et al.
The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E413 - E419.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Fleischman, S. E. Shoelson, R. Bernier, and A. B. Goldfine
Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Diabetes Care, February 1, 2008; 31(2): 289 - 294.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Grundy
Gamma-Glutamyl Transferase: Another Biomarker for Metabolic Syndrome and Cardiovascular Risk
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 4 - 7.
[Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
J. W. Choi, J. S. Song, and S. H. Pai
Associations of Serum TRAIL Concentrations, Anthropometric Variables, and Serum Lipid Parameters in Healthy Adults
Ann. Clin. Lab. Sci., October 1, 2004; 34(4): 400 - 404.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association of Clinical Scientists.